Viewing Study NCT00114959

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:54 PM
Ignite Modification Date: 2026-02-08 @ 1:16 AM
Study NCT ID: NCT00114959
Status: TERMINATED
Last Update Posted: 2015-01-15
First Post: 2005-06-20
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)
Sponsor: ChemGenex Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myeloid Leukemia, Chronic View
None Myeloid Leukemia, Chronic, Accelerated-Phase View
None Blast Phase View
None Myeloid Leukemia, Chronic, Chronic-Phase View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ChemGenex Pharmaceuticals, Ltd View
None ChemGenex Pharmaceuticals View
None ChemGenex View
None Chronic Myeloid Leukemia View
None Myeloid Leukemia, Chronic View
None Leukemia View
None Myeloid Leukemia View
None Chronic Phase View
None Accelerated Phase View
None Blast Phase View
None Myeloid, Leukemia, Chronic, Accelerated Phase View
None Myeloid, Leukemia, Chronic View
None Leukemia, Myeloid, Chronic View
None Leukemia, Myeloid, Chronic-Phase View
None Leukemia, Myeloid, Chronic Phase View
None Leukemia, Myeloid, Accelerated-Phase View
None Myeloid, Leukemia, Chronic, Chronic Phase View
None Leukemia, Myeloid, Accelerated Phase View
None Homoharringtonine View
None Omacetaxine View